T.N SRINIVASAN, M.D., Research Consultant, Schizophrenia Research Foundation (India), Plot R/7A, West Main Road, Chennai-600101.
Indian J Psychiatry. 1998 Jan;40(1):70-2.
Use of clozapine is attended with the serious though rare risk of agranulocytosis. Clozapineinduced agranulocytosis is reversible with the use of cytokines like granulocyte-colony stimulating factor (G-CSF). Reports of the haematological complication of clozapine have not been forthcoming from India though it has been in use for nearly three years. This report is on an young patient who developed total absence of granulocytes during the 4th month of treatment who was successfully treated with G-CSF.
氯氮平的使用伴随着严重但罕见的粒细胞缺乏症风险。使用粒细胞集落刺激因子(G-CSF)等细胞因子可逆转氯氮平引起的粒细胞缺乏症。尽管氯氮平在印度已经使用了近三年,但尚未有关于其血液学并发症的报告。本报告介绍了一位年轻患者,在治疗的第 4 个月出现了完全缺乏粒细胞的情况,使用 G-CSF 成功治疗。